how many people are using glp-1 Rising use of medications among women with PCOS US households with GLP-1 users

Peroxynitrite-mediated lipid oxidation and nitration: mechanisms and consequences

Santra, & B

Michael Somenek, a clinical investigator in the groundbreaking Galderma study, notes that as medication-driven weight loss becomes more prolific around the world, so do the associated impacts of facial volume loss and other unwanted cosmetic effects like shadowing and hollowness. The Science Behind Facial Changes with GLP-1 Medications The 2025 Galderma clinical trial confirms what weve been observing in our practice at Aestha Clinic

Meanwhile, L-carnitine may play a role in supporting heart function by aiding cellular energy production in cardiac tissue

TRANSLATING RESEARCH INTO PRACTICE Rajesh R

Interstitial cystitis: enhancing early identification in primary care settings